Free Trial

Forian (NASDAQ:FORA) Stock Price Up 1% - Here's Why

Forian logo with Medical background

Forian Inc. (NASDAQ:FORA - Get Free Report) shares traded up 1% during trading on Tuesday . The stock traded as high as $2.06 and last traded at $2.05. 4,898 shares were traded during trading, a decline of 56% from the average session volume of 11,125 shares. The stock had previously closed at $2.03.

Wall Street Analyst Weigh In

Separately, Roth Mkm restated a "buy" rating and set a $5.00 price objective on shares of Forian in a research report on Thursday, November 14th.

Read Our Latest Analysis on Forian

Forian Stock Performance

The firm has a market cap of $63.58 million, a P/E ratio of -22.78 and a beta of 1.05. The stock has a 50 day simple moving average of $2.05 and a 200-day simple moving average of $2.26.

Hedge Funds Weigh In On Forian

An institutional investor recently raised its position in Forian stock. Canton Hathaway LLC boosted its stake in shares of Forian Inc. (NASDAQ:FORA - Free Report) by 2.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 269,650 shares of the company's stock after buying an additional 6,125 shares during the period. Canton Hathaway LLC owned approximately 0.87% of Forian worth $582,000 at the end of the most recent quarter. 19.25% of the stock is currently owned by institutional investors.

Forian Company Profile

(Get Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

Further Reading

Should You Invest $1,000 in Forian Right Now?

Before you consider Forian, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Forian wasn't on the list.

While Forian currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines